ACE2 and COVID-19: The systemic manifestations of COVID-19 vary, but these complications are largely interwoven by certain shared mechanisms, involving direct viral cytotoxicity, immune disturbances, endothelial damage and thromboinflammation, and ACE2-associated RAS system dysregulation.